ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors
Clinical trial NCT01110486 · COMPLETED
Trial details
- NCT number
- NCT01110486
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-09-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.